Axel Bex
0000-0002-8499-2662
Publication & Citation Trends
Publications
607 total
The CAMUS Initiative: A Multiphase, Multicentre International Collaboration to Redefine Risk Stratification, Reporting, and Grading of Surgical Complications in Urology
Cited by 0
Semantic Scholar
Quality Indicators for Renal Cancer Care: A Systematic Review.
Cited by 4
Semantic Scholar
Exploratory analysis from NEOAVAX, a neoadjuvant trial of avelumab/axitinib in patients (pts) with localized renal cell carcinoma (RCC) who are at high risk of relapse after nephrectomy.
Cited by 3
Semantic Scholar
36International neoadjuvant kidney cancer consortium guidelines on assessing pathological response after neoadjuvant therapy in kidney cancer
Cited by 0
Semantic Scholar
11Exploring Health-Related quality of life across the disease spectrum in renal cell carcinoma: a conceptual domain analysis
Cited by 0
Semantic Scholar
Genomic characterization of baseline and post-progression tumors in IMmotion010, a randomized, phase 3 study of adjuvant (adj) atezolizumab (atezo) vs placebo (pbo) in patients (pts) with high-risk localized renal cell carcinoma (RCC).
Cited by 0
Semantic Scholar
66Patient perceptions of biomarker testing in kidney cancer (KC) from the international kidney cancer coalition (IKCC) global patient survey (GPS)
Cited by 0
Semantic Scholar
Assessing pathological response to neoadjuvant therapy in renal cell carcinoma: a systematic review and guidelines for sampling and reporting standards from the International Neoadjuvant Kidney Cancer Consortium.
Cited by 5
Semantic Scholar
Research Topics
Renal cell carcinoma treatment
(421)
Renal and related cancers
(221)
Bladder and Urothelial Cancer Treatments
(155)
Cancer Genomics and Diagnostics
(139)
Cancer Immunotherapy and Biomarkers
(68)
Affiliations
National Health Service
St Bartholomew's Hospital
Memorial Sloan Kettering Cancer Center
The University of Texas MD Anderson Cancer Center
Institute of Cancer Research